DAPSONE
ALEMBIC · DAPSONE
Open FDA's page for this record- Application number
- ANDA213414
- Sponsor name
- ALEMBIC
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20260625
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- DAPSONE
- Reference standard
- No
- Dosage form
- GEL
- Route
- TOPICAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- DAPSONE
- Strength
- 5%
- Harmonized identifiers (openFDA)
- Application number
- ANDA213414
- Brand name
- DAPSONE
- Generic name
- DAPSONE
- Manufacturer name
- Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Limited
- Product NDC
- 62332-551, 46708-551
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- TOPICAL
- Substance name
- DAPSONE
- RxCUI
- 607295
- SPL ID
- d9849120-ccaa-4820-8e8d-3a8c7d809ffb, 1a5c37bb-155e-4a03-afc6-4a4ef1f9dce1
- SPL set ID
- 7249f655-1d8e-482a-889a-1e7e1a19500c, 0f1301f6-884d-4fc7-a5b2-421b2375b985
- Package NDC
- 62332-551-60, 62332-551-90, 62332-551-30, 46708-551-60, 46708-551-90, 46708-551-30
- Nui
- N0000175881, M0020791
- Pharm class epc
- Sulfone [EPC]
- Pharm class cs
- Sulfones [CS]
- UNII
- 8W5C518302
